questionsmedicales.fr
Maladies métaboliques et nutritionnelles
Maladies métaboliques
Erreurs innées du métabolisme
Maladies lysosomiales
Maladies neurologiques de surcharge lysosomiale
Maladies neurologiques de surcharge lysosomiale : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Maladies lysosomales
Diagnostic médical
Biopsie
Imagerie par résonance magnétique
Symptômes neurologiques
Maladies lysosomales
Antécédents familiaux
Maladies héréditaires
Diagnostic prénatal
Maladies lysosomales
Symptômes
5
Symptômes neurologiques
Troubles du développement
Maladies lysosomales
Symptômes neurologiques
Troubles psychologiques
Maladies neurologiques
Âge d'apparition
Maladies neurologiques
Symptômes neurologiques
Maladies dégénératives
Prévention
5
Prévention
Dépistage génétique
Conseil génétique
Maladies héréditaires
Vaccination
Prévention des maladies
Dépistage
Planification familiale
Traitements
5
Thérapie enzymatique
Traitement médical
Thérapie génique
Maladies lysosomales
Médicaments
Symptômes neurologiques
Essais cliniques
Traitements expérimentaux
Physiothérapie
Réhabilitation
Complications
5
Complications
Maladies neurologiques
Gestion des complications
Traitement précoce
Qualité de vie
Complications
Mortalité
Maladies lysosomales
Complications
Gestion à long terme
Facteurs de risque
5
Facteurs de risque
Maladies héréditaires
Âge parental
Facteurs de risque
Origines ethniques
Maladies héréditaires
Facteurs environnementaux
Maladies génétiques
Hérédité
Maladies lysosomales
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Maladies neurologiques de surcharge lysosomiale : Questions médicales les plus fréquentes",
"headline": "Maladies neurologiques de surcharge lysosomiale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Maladies neurologiques de surcharge lysosomiale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-01",
"dateModified": "2026-01-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Maladies neurologiques de surcharge lysosomiale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies lysosomiales",
"url": "https://questionsmedicales.fr/mesh/D016464",
"about": {
"@type": "MedicalCondition",
"name": "Maladies lysosomiales",
"code": {
"@type": "MedicalCode",
"code": "D016464",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Fucosidose",
"alternateName": "Fucosidosis",
"url": "https://questionsmedicales.fr/mesh/D005645",
"about": {
"@type": "MedicalCondition",
"name": "Fucosidose",
"code": {
"@type": "MedicalCode",
"code": "D005645",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.295"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glycogénose de type II",
"alternateName": "Glycogen Storage Disease Type II",
"url": "https://questionsmedicales.fr/mesh/D006009",
"about": {
"@type": "MedicalCondition",
"name": "Glycogénose de type II",
"code": {
"@type": "MedicalCode",
"code": "D006009",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.340"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mucolipidoses",
"alternateName": "Mucolipidoses",
"url": "https://questionsmedicales.fr/mesh/D009081",
"about": {
"@type": "MedicalCondition",
"name": "Mucolipidoses",
"code": {
"@type": "MedicalCode",
"code": "D009081",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.590"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de surcharge en acide sialique",
"alternateName": "Sialic Acid Storage Disease",
"url": "https://questionsmedicales.fr/mesh/D029461",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de surcharge en acide sialique",
"code": {
"@type": "MedicalCode",
"code": "D029461",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.810"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sphingolipidoses",
"alternateName": "Sphingolipidoses",
"url": "https://questionsmedicales.fr/mesh/D013106",
"about": {
"@type": "MedicalCondition",
"name": "Sphingolipidoses",
"code": {
"@type": "MedicalCode",
"code": "D013106",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Maladie de Fabry",
"alternateName": "Fabry Disease",
"url": "https://questionsmedicales.fr/mesh/D000795",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Fabry",
"code": {
"@type": "MedicalCode",
"code": "D000795",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lipogranulomatose de Farber",
"alternateName": "Farber Lipogranulomatosis",
"url": "https://questionsmedicales.fr/mesh/D055577",
"about": {
"@type": "MedicalCondition",
"name": "Lipogranulomatose de Farber",
"code": {
"@type": "MedicalCode",
"code": "D055577",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gangliosidoses",
"alternateName": "Gangliosidoses",
"url": "https://questionsmedicales.fr/mesh/D005733",
"about": {
"@type": "MedicalCondition",
"name": "Gangliosidoses",
"code": {
"@type": "MedicalCode",
"code": "D005733",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.300"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gangliosidoses à GM2",
"alternateName": "Gangliosidoses, GM2",
"url": "https://questionsmedicales.fr/mesh/D020143",
"about": {
"@type": "MedicalCondition",
"name": "Gangliosidoses à GM2",
"code": {
"@type": "MedicalCode",
"code": "D020143",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.300.300"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Maladie de Sandhoff",
"alternateName": "Sandhoff Disease",
"url": "https://questionsmedicales.fr/mesh/D012497",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Sandhoff",
"code": {
"@type": "MedicalCode",
"code": "D012497",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.300.300.800"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Tay-Sachs",
"alternateName": "Tay-Sachs Disease",
"url": "https://questionsmedicales.fr/mesh/D013661",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Tay-Sachs",
"code": {
"@type": "MedicalCode",
"code": "D013661",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.300.300.840"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Tay-Sachs variante AB",
"alternateName": "Tay-Sachs Disease, AB Variant",
"url": "https://questionsmedicales.fr/mesh/D049290",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Tay-Sachs variante AB",
"code": {
"@type": "MedicalCode",
"code": "D049290",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.300.300.920"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Sandhoff",
"alternateName": "Sandhoff Disease",
"url": "https://questionsmedicales.fr/mesh/D012497",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Sandhoff",
"code": {
"@type": "MedicalCode",
"code": "D012497",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.300.300.800"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Tay-Sachs",
"alternateName": "Tay-Sachs Disease",
"url": "https://questionsmedicales.fr/mesh/D013661",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Tay-Sachs",
"code": {
"@type": "MedicalCode",
"code": "D013661",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.300.300.840"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Tay-Sachs variante AB",
"alternateName": "Tay-Sachs Disease, AB Variant",
"url": "https://questionsmedicales.fr/mesh/D049290",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Tay-Sachs variante AB",
"code": {
"@type": "MedicalCode",
"code": "D049290",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.300.300.920"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gangliosidose à GM1",
"alternateName": "Gangliosidosis, GM1",
"url": "https://questionsmedicales.fr/mesh/D016537",
"about": {
"@type": "MedicalCondition",
"name": "Gangliosidose à GM1",
"code": {
"@type": "MedicalCode",
"code": "D016537",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.300.400"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Gangliosidoses à GM2",
"alternateName": "Gangliosidoses, GM2",
"url": "https://questionsmedicales.fr/mesh/D020143",
"about": {
"@type": "MedicalCondition",
"name": "Gangliosidoses à GM2",
"code": {
"@type": "MedicalCode",
"code": "D020143",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.300.300"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Maladie de Sandhoff",
"alternateName": "Sandhoff Disease",
"url": "https://questionsmedicales.fr/mesh/D012497",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Sandhoff",
"code": {
"@type": "MedicalCode",
"code": "D012497",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.300.300.800"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Tay-Sachs",
"alternateName": "Tay-Sachs Disease",
"url": "https://questionsmedicales.fr/mesh/D013661",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Tay-Sachs",
"code": {
"@type": "MedicalCode",
"code": "D013661",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.300.300.840"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Tay-Sachs variante AB",
"alternateName": "Tay-Sachs Disease, AB Variant",
"url": "https://questionsmedicales.fr/mesh/D049290",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Tay-Sachs variante AB",
"code": {
"@type": "MedicalCode",
"code": "D049290",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.300.300.920"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Sandhoff",
"alternateName": "Sandhoff Disease",
"url": "https://questionsmedicales.fr/mesh/D012497",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Sandhoff",
"code": {
"@type": "MedicalCode",
"code": "D012497",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.300.300.800"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Tay-Sachs",
"alternateName": "Tay-Sachs Disease",
"url": "https://questionsmedicales.fr/mesh/D013661",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Tay-Sachs",
"code": {
"@type": "MedicalCode",
"code": "D013661",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.300.300.840"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Tay-Sachs variante AB",
"alternateName": "Tay-Sachs Disease, AB Variant",
"url": "https://questionsmedicales.fr/mesh/D049290",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Tay-Sachs variante AB",
"code": {
"@type": "MedicalCode",
"code": "D049290",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.300.300.920"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gangliosidose à GM1",
"alternateName": "Gangliosidosis, GM1",
"url": "https://questionsmedicales.fr/mesh/D016537",
"about": {
"@type": "MedicalCondition",
"name": "Gangliosidose à GM1",
"code": {
"@type": "MedicalCode",
"code": "D016537",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.300.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Gaucher",
"alternateName": "Gaucher Disease",
"url": "https://questionsmedicales.fr/mesh/D005776",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Gaucher",
"code": {
"@type": "MedicalCode",
"code": "D005776",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Leucodystrophie à cellules globoïdes",
"alternateName": "Leukodystrophy, Globoid Cell",
"url": "https://questionsmedicales.fr/mesh/D007965",
"about": {
"@type": "MedicalCondition",
"name": "Leucodystrophie à cellules globoïdes",
"code": {
"@type": "MedicalCode",
"code": "D007965",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.590"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladies de Niemann-Pick",
"alternateName": "Niemann-Pick Diseases",
"url": "https://questionsmedicales.fr/mesh/D009542",
"about": {
"@type": "MedicalCondition",
"name": "Maladies de Niemann-Pick",
"code": {
"@type": "MedicalCode",
"code": "D009542",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.700"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Maladie de Niemann-Pick de type A",
"alternateName": "Niemann-Pick Disease, Type A",
"url": "https://questionsmedicales.fr/mesh/D052536",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Niemann-Pick de type A",
"code": {
"@type": "MedicalCode",
"code": "D052536",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.700.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Niemann-Pick de type B",
"alternateName": "Niemann-Pick Disease, Type B",
"url": "https://questionsmedicales.fr/mesh/D052537",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Niemann-Pick de type B",
"code": {
"@type": "MedicalCode",
"code": "D052537",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.700.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Niemann-Pick de type C",
"alternateName": "Niemann-Pick Disease, Type C",
"url": "https://questionsmedicales.fr/mesh/D052556",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Niemann-Pick de type C",
"code": {
"@type": "MedicalCode",
"code": "D052556",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.700.875"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Niemann-Pick de type A",
"alternateName": "Niemann-Pick Disease, Type A",
"url": "https://questionsmedicales.fr/mesh/D052536",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Niemann-Pick de type A",
"code": {
"@type": "MedicalCode",
"code": "D052536",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.700.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Niemann-Pick de type B",
"alternateName": "Niemann-Pick Disease, Type B",
"url": "https://questionsmedicales.fr/mesh/D052537",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Niemann-Pick de type B",
"code": {
"@type": "MedicalCode",
"code": "D052537",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.700.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Niemann-Pick de type C",
"alternateName": "Niemann-Pick Disease, Type C",
"url": "https://questionsmedicales.fr/mesh/D052556",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Niemann-Pick de type C",
"code": {
"@type": "MedicalCode",
"code": "D052556",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.700.875"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndrome des histiocytes bleus de mer",
"alternateName": "Sea-Blue Histiocyte Syndrome",
"url": "https://questionsmedicales.fr/mesh/D012618",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome des histiocytes bleus de mer",
"code": {
"@type": "MedicalCode",
"code": "D012618",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.775"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfatidose",
"alternateName": "Sulfatidosis",
"url": "https://questionsmedicales.fr/mesh/D052516",
"about": {
"@type": "MedicalCondition",
"name": "Sulfatidose",
"code": {
"@type": "MedicalCode",
"code": "D052516",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.850"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Leucodystrophie métachromatique",
"alternateName": "Leukodystrophy, Metachromatic",
"url": "https://questionsmedicales.fr/mesh/D007966",
"about": {
"@type": "MedicalCondition",
"name": "Leucodystrophie métachromatique",
"code": {
"@type": "MedicalCode",
"code": "D007966",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.850.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Déficit multiple en sulfatases",
"alternateName": "Multiple Sulfatase Deficiency Disease",
"url": "https://questionsmedicales.fr/mesh/D052517",
"about": {
"@type": "MedicalCondition",
"name": "Déficit multiple en sulfatases",
"code": {
"@type": "MedicalCode",
"code": "D052517",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.850.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Leucodystrophie métachromatique",
"alternateName": "Leukodystrophy, Metachromatic",
"url": "https://questionsmedicales.fr/mesh/D007966",
"about": {
"@type": "MedicalCondition",
"name": "Leucodystrophie métachromatique",
"code": {
"@type": "MedicalCode",
"code": "D007966",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.850.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Déficit multiple en sulfatases",
"alternateName": "Multiple Sulfatase Deficiency Disease",
"url": "https://questionsmedicales.fr/mesh/D052517",
"about": {
"@type": "MedicalCondition",
"name": "Déficit multiple en sulfatases",
"code": {
"@type": "MedicalCode",
"code": "D052517",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.595.554.825.850.750"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Maladies neurologiques de surcharge lysosomiale",
"alternateName": "Lysosomal Storage Diseases, Nervous System",
"code": {
"@type": "MedicalCode",
"code": "D020140",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Valeria De Pasquale",
"url": "https://questionsmedicales.fr/author/Valeria%20De%20Pasquale",
"affiliation": {
"@type": "Organization",
"name": "Department of Veterinary Medicine and Animal Productions, University of Naples Federico II, Via Federico Delpino 1, 80137 Naples, Italy."
}
},
{
"@type": "Person",
"name": "Luigi Michele Pavone",
"url": "https://questionsmedicales.fr/author/Luigi%20Michele%20Pavone",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Via Sergio Pansini 5, 80131 Naples, Italy."
}
},
{
"@type": "Person",
"name": "Melania Scarcella",
"url": "https://questionsmedicales.fr/author/Melania%20Scarcella",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Via Sergio Pansini 5, 80131 Naples, Italy."
}
},
{
"@type": "Person",
"name": "Estera Rintz",
"url": "https://questionsmedicales.fr/author/Estera%20Rintz",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Biology, Faculty of Biology, University of Gdansk, Gdansk, Poland."
}
},
{
"@type": "Person",
"name": "Ellen Sidransky",
"url": "https://questionsmedicales.fr/author/Ellen%20Sidransky",
"affiliation": {
"@type": "Organization",
"name": "Molecular Neurogenetics Section, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: sidranse@mail.nih.gov."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "[Lysosomal storage disorders - Fabry disease and Gaucher disease].",
"datePublished": "2024-10-09",
"url": "https://questionsmedicales.fr/article/39384207",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-2295-1592"
}
},
{
"@type": "ScholarlyArticle",
"name": "Use of Ambroxol as Therapy for Gaucher Disease.",
"datePublished": "2023-06-01",
"url": "https://questionsmedicales.fr/article/37342037",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamanetworkopen.2023.19364"
}
},
{
"@type": "ScholarlyArticle",
"name": "Changing clinical manifestations of Gaucher disease in Taiwan.",
"datePublished": "2023-09-15",
"url": "https://questionsmedicales.fr/article/37715271",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13023-023-02895-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Histologically atypical case of Gaucher disease type 1.",
"datePublished": "2023-09-29",
"url": "https://questionsmedicales.fr/article/37775277",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bcr-2023-256368"
}
},
{
"@type": "ScholarlyArticle",
"name": "Gaucher disease in a patient with membranoproliferative glomerulonephritis: case report.",
"datePublished": "2023-09-29",
"url": "https://questionsmedicales.fr/article/37773105",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12882-023-03163-9"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies métaboliques et nutritionnelles",
"item": "https://questionsmedicales.fr/mesh/D009750"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies métaboliques",
"item": "https://questionsmedicales.fr/mesh/D008659"
},
{
"@type": "ListItem",
"position": 4,
"name": "Erreurs innées du métabolisme",
"item": "https://questionsmedicales.fr/mesh/D008661"
},
{
"@type": "ListItem",
"position": 5,
"name": "Maladies lysosomiales",
"item": "https://questionsmedicales.fr/mesh/D016464"
},
{
"@type": "ListItem",
"position": 6,
"name": "Maladies neurologiques de surcharge lysosomiale",
"item": "https://questionsmedicales.fr/mesh/D020140"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Maladies neurologiques de surcharge lysosomiale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Maladies neurologiques de surcharge lysosomiale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-02-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Maladies neurologiques de surcharge lysosomiale",
"description": "Comment diagnostique-t-on ces maladies ?\nQuels tests sont utilisés pour le diagnostic ?\nLes symptômes aident-ils au diagnostic ?\nLes antécédents familiaux sont-ils importants ?\nPeut-on diagnostiquer in utero ?",
"url": "https://questionsmedicales.fr/mesh/D020140?mesh_terms=Gaucher+Disease#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Maladies neurologiques de surcharge lysosomiale",
"description": "Quels sont les symptômes courants ?\nLes symptômes varient-ils selon la maladie ?\nY a-t-il des symptômes psychologiques associés ?\nLes symptômes apparaissent-ils à un âge spécifique ?\nLes symptômes sont-ils réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D020140?mesh_terms=Gaucher+Disease#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Maladies neurologiques de surcharge lysosomiale",
"description": "Peut-on prévenir ces maladies ?\nLe conseil génétique est-il recommandé ?\nLes vaccinations sont-elles importantes ?\nY a-t-il des mesures préventives spécifiques ?\nLes tests de dépistage sont-ils utiles ?",
"url": "https://questionsmedicales.fr/mesh/D020140?mesh_terms=Gaucher+Disease#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Maladies neurologiques de surcharge lysosomiale",
"description": "Quels traitements sont disponibles ?\nLa thérapie génique est-elle une option ?\nLes médicaments peuvent-ils soulager les symptômes ?\nY a-t-il des traitements expérimentaux ?\nLa physiothérapie est-elle bénéfique ?",
"url": "https://questionsmedicales.fr/mesh/D020140?mesh_terms=Gaucher+Disease#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Maladies neurologiques de surcharge lysosomiale",
"description": "Quelles complications peuvent survenir ?\nLes complications sont-elles évitables ?\nLes complications affectent-elles la qualité de vie ?\nY a-t-il des risques de décès ?\nLes complications sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D020140?mesh_terms=Gaucher+Disease#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Maladies neurologiques de surcharge lysosomiale",
"description": "Quels sont les facteurs de risque génétiques ?\nL'âge des parents influence-t-il le risque ?\nLes origines ethniques jouent-elles un rôle ?\nY a-t-il des facteurs environnementaux ?\nLes maladies lysosomales sont-elles héréditaires ?",
"url": "https://questionsmedicales.fr/mesh/D020140?mesh_terms=Gaucher+Disease#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on ces maladies ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests génétiques, des analyses enzymatiques et des imageries cérébrales."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins, des biopsies et des examens d'imagerie comme l'IRM sont courants."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes neurologiques spécifiques orientent souvent vers un diagnostic précoce."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux sont-ils importants ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents familiaux de maladies lysosomales peuvent indiquer un risque accru."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer in utero ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests génétiques peuvent être réalisés pendant la grossesse pour certaines maladies."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles moteurs, des convulsions, et des retards de développement."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon la maladie ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque maladie lysosomale présente un ensemble unique de symptômes neurologiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes psychologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de l'humeur et des problèmes cognitifs peuvent également se manifester."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils à un âge spécifique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent apparaître à différents âges, souvent dans l'enfance ou l'adolescence."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils réversibles ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes sont généralement progressifs et irréversibles sans traitement approprié."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir ces maladies ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est limitée, mais le dépistage génétique peut aider à identifier les porteurs."
}
},
{
"@type": "Question",
"name": "Le conseil génétique est-il recommandé ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le conseil génétique est conseillé pour les familles à risque de maladies lysosomales."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations ne préviennent pas les maladies lysosomales, mais sont essentielles pour la santé générale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives spécifiques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucune mesure préventive spécifique n'existe, mais un suivi médical régulier est conseillé."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils utiles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests de dépistage peuvent identifier les porteurs et aider à la planification familiale."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie enzymatique de remplacement et la gestion des symptômes."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie génique est en cours d'étude pour certaines maladies lysosomales."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils soulager les symptômes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments peuvent aider à gérer les symptômes neurologiques et comportementaux."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des essais cliniques explorent de nouvelles approches thérapeutiques pour ces maladies."
}
},
{
"@type": "Question",
"name": "La physiothérapie est-elle bénéfique ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la physiothérapie peut aider à améliorer la mobilité et la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles neurologiques graves, des problèmes cardiaques et respiratoires."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles évitables ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais beaucoup sont inévitables sans traitement précoce."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications neurologiques peuvent gravement affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de décès ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies lysosomales peuvent entraîner un risque accru de mortalité précoce."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la plupart des complications sont irréversibles et nécessitent une gestion à long terme."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque génétiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux de maladies lysosomales augmentent le risque de transmission génétique."
}
},
{
"@type": "Question",
"name": "L'âge des parents influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge avancé des parents peut augmenter le risque de mutations génétiques."
}
},
{
"@type": "Question",
"name": "Les origines ethniques jouent-elles un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines populations ont un risque plus élevé de maladies lysosomales en raison de la consanguinité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, les facteurs environnementaux ne sont pas clairement établis comme des risques."
}
},
{
"@type": "Question",
"name": "Les maladies lysosomales sont-elles héréditaires ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la plupart des maladies lysosomales sont héréditaires et se transmettent selon des modèles génétiques."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/01/2026
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Veterinary Medicine and Animal Productions, University of Naples Federico II, Via Federico Delpino 1, 80137 Naples, Italy.
Publications dans "Maladies neurologiques de surcharge lysosomiale" :
4 publications dans cette catégorie
Affiliations :
Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Via Sergio Pansini 5, 80131 Naples, Italy.
Publications dans "Maladies neurologiques de surcharge lysosomiale" :
3 publications dans cette catégorie
Affiliations :
Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Via Sergio Pansini 5, 80131 Naples, Italy.
Publications dans "Maladies neurologiques de surcharge lysosomiale" :
3 publications dans cette catégorie
Affiliations :
Department of Molecular Biology, Faculty of Biology, University of Gdansk, Gdansk, Poland.
Publications dans "Maladies neurologiques de surcharge lysosomiale" :
3 publications dans cette catégorie
Affiliations :
Molecular Neurogenetics Section, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: sidranse@mail.nih.gov.
Publications dans "Maladies neurologiques de surcharge lysosomiale" :
2 publications dans cette catégorie
Affiliations :
Cell and Developmental Biology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Publications dans "Maladies neurologiques de surcharge lysosomiale" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology, University of Oxford, Oxford, UK. frances.platt@pharm.ox.ac.uk.
Publications dans "Maladies neurologiques de surcharge lysosomiale" :
2 publications dans cette catégorie
Affiliations :
Office of the Clinical Director and Medical Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, MD, USA.
Publications dans "Maladies neurologiques de surcharge lysosomiale" :
2 publications dans cette catégorie
Affiliations :
1 University of Florida, Departments of Pediatrics, Division of Genetics and Metabolism, Neuroscience and Molecular Genetics & Microbiology, Gainesville, FL, USA.
Publications dans "Maladies neurologiques de surcharge lysosomiale" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Via Sergio Pansini 5, 80131 Naples, Italy.
Publications dans "Maladies neurologiques de surcharge lysosomiale" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Via Sergio Pansini 5, 80131 Naples, Italy.
Publications dans "Maladies neurologiques de surcharge lysosomiale" :
2 publications dans cette catégorie
Affiliations :
Telethon Institute of Genetics and Medicine, Pozzuoli, Italy.
Department of Translational Medical Sciences, Section of Pediatrics, Federico II University, Naples, Italy.
Publications dans "Maladies neurologiques de surcharge lysosomiale" :
2 publications dans cette catégorie
Affiliations :
Institute for the Study of Inborn Errors of Metabolism, Faculty of Science, Pontificia Universidad Javeriana, Cra. 7 No. 43-82 Building 54, Room 305A, Bogotá D.C, 110231, Colombia.
Publications dans "Maladies neurologiques de surcharge lysosomiale" :
2 publications dans cette catégorie
Affiliations :
Institute for the Study of Inborn Errors of Metabolism, Faculty of Science, Pontificia Universidad Javeriana, Cra. 7 No. 43-82 Building 54, Room 305A, Bogotá D.C, 110231, Colombia. cjalmeciga@javeriana.edu.co.
Publications dans "Maladies neurologiques de surcharge lysosomiale" :
2 publications dans cette catégorie
Affiliations :
Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Publications dans "Maladies neurologiques de surcharge lysosomiale" :
2 publications dans cette catégorie
Affiliations :
Department of Genetics, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
Gene Therapy Center, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Publications dans "Maladies neurologiques de surcharge lysosomiale" :
2 publications dans cette catégorie
Affiliations :
Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE, USA; Department of Molecular Biology, Faculty of Biology, University of Gdansk, Gdansk, Poland; Faculty of Arts and Sciences, University of Delaware, Newark, DE, USA; Department of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan; Department of Pediatrics, Thomas Jefferson University, Philadelphia, PA, USA. Electronic address: shunji.tomatsu@nemours.com.
Publications dans "Maladies neurologiques de surcharge lysosomiale" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatric Metabolism, Ankara Bilkent City Hospital, Ankara, Turkey.
Publications dans "Maladies neurologiques de surcharge lysosomiale" :
2 publications dans cette catégorie
Affiliations :
Department of Cell Modulation, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan; Department of Pediatrics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan. Electronic address: kidojun@kuh.kumamoto-u.ac.jp.
Publications dans "Maladies neurologiques de surcharge lysosomiale" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Publications dans "Maladies neurologiques de surcharge lysosomiale" :
Lysosomal storage disorders (LSD) are a heterogenous group of inborn errors of metabolism due to lysosomal malfunction. LSDs affect 1 in 5000 live births, albeit every LSD itself has a low incidence. ...
Ambroxol was identified as an enhancer of stability and residual activity of several misfolded glucocerebrosidase variants in 2009....
To assess hematologic and visceral outcomes, biomarker changes, and safety of ambroxol therapy for patients with Gaucher disease (GD) without disease-specific treatment....
Patients with GD who could not afford enzyme replacement therapy were enrolled and received oral ambroxol from May 6, 2015, to November 9, 2022, at Xinhua Hospital, affiliated with Shanghai Jiao Tong ...
An escalating dose of oral ambroxol (mean [SD] dose, 12.7 [3.9] mg/kg/d)....
Patients with GD receiving ambroxol were followed up in a genetic metabolism center. Biomarkers of chitotriosidase activity and glucosylsphingosine level, liver and spleen volumes, and hematologic par...
A total of 28 patients (mean [SD] age, 16.9 [15.3] years; 15 male patients [53.6%]) received ambroxol for a mean (SD) duration of 2.6 (1.7) years. Two patients with severe symptoms at baseline experie...
In this case series of ambroxol repurposing among patients with GD, long-term treatment with ambroxol was safe and associated with patient improvement. Improvements in hematologic parameters, visceral...
Gaucher disease (GD) is a lysosomal storage disorder characterized by deficient glucocerebrosidase activity that results from biallelic mutations in the GBA1 gene. Its phenotypic variability allows GD...
Data from the health records of two tertiary hospitals responsible for two-thirds of the patients with GD in Taiwan were used. The study population included all patients identified as having GD betwee...
Our cohort presented a higher proportion of GD3 individuals, both by clinical suspicion and by NBS diagnosis, than that reported worldwide. The major subtypes that were recognized following NBS diagno...
ERT is essential in reversing the hematological presentations and preventing the skeletal complications of GD. Timely diagnosis of GD with NBS allows for early intervention with ERT to prevent disease...
This report presents a case of childhood Gaucher disease type 1, a rare inherited metabolic disorder. Although the clinical symptoms were classical, the histological findings in this case were atypica...
Gaucher disease (GD) is a rare autosomal recessive inherited, lysosomal storage disoder that involves liver, spleen, lung, bone, bone marrow even central nervous. However, GD associated membranoprolif...
Here we described a case of 35-year-old man suffering from GD with hepatosplenomegaly, ascites, bone destruction, myelofibrosis and MPGN. Renal biopsy revealed MPGN and Gaucher cells presented in the ...
Therapy of prednisone and mycophenolate mofetil may be an optional choice for patients with Gaucher disease who have no opportunity to use enzyme treatment....
Gaucher's disease (GD), a rare condition, represents the most common lysosomal storage disorder. The cardinal manifestations of GD are fatigue, hepatosplenomegaly, anemia, thrombocytopenia, bone pain,...
We systematically searched PubMed, Web of Science Core Collections, EMBASE, SCOPUS, Cochrane Library, PsycINFO, Wan Fang Data, China National Knowledge Infrastructure (CNKI), and the Chinese Biomedica...
A total of 33 studies were identified, encompassing 24 distinct patient-reported outcome instruments, with the most frequently employed instrument being the SF-36. The study designs included eighteen ...
PROs have garnered increased attention and concern in the realm of GD. Despite this progress, it is noteworthy that the instruments used to measure PROs in GD are still predominantly generic instrumen...
Gaucher disease (GD) is caused by glucocerebrosidase (GCase) enzyme deficiency, leading to glycosylceramide (Gb-1) and glucosylsphingosine (Lyso-Gb-1) accumulation. The pathological hallmark for GD is...
39 patients with GD were categorized into cohorts based on bone mineral density (BMD). TRAP5a and TRAP5b plasma levels were quantified by ELISA. ACP5 mRNA was estimated using RT-PCR....
An increase in TRAP5b was associated with reduced BMD and correlated with Lyso-Gb-1 and immune activator chemokine ligand 18 (CCL18). In contrast, the elevation of TRAP5a correlated with chitotriosida...
As an early indicator of BMD alteration, measurement of circulating TRAP5b is a valuable tool for assessing osteopenia-osteoporosis in GD, while TRAP5a serves as a biomarker of macrophage activation i...
Our ability to identify different variants in GBA1, the gene mutated in the lysosomal storage disorder Gaucher disease (GD), has greatly improved. We describe a multigenerational family with type 1 GD...
Gaucher's disease (GD) is a lysosomal storage disorder characterized by the storage of glucosylceramide in macrophages ("Gaucher cells"), mainly in the reticuloendothelial system. GD type 1 (GD1) is t...
Lysosomes function as a primary site for catabolism and cellular signaling. These organelles digest a variety of substrates received through endocytosis, secretion and autophagy with the help of resid...